Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Ann Clin Microbiol Antimicrob ; 18(1): 27, 2019 Sep 24.
Artigo em Inglês | MEDLINE | ID: mdl-31551072

RESUMO

BACKGROUND: Identification of all possible HIV reservoirs is an important aspect in HIV eradication efforts. The urinary tract has however not been well studied as a potential HIV reservoir. In this pilot study we molecularly characterized HIV-1 viruses in urine and plasma samples to investigate HIV-1 replication, compartmentalization and persistence in the urinary tract. METHODS: Prospectively collected urine and blood samples collected over 12-36 months from 20 HIV-1 infected individuals were analysed including sampling points from prior to and after ART initiation. HIV-1 pol gene RNA and DNA from urine supernatant and urine pellets respectively were analysed and compared to plasma RNA viruses from the same individual. RESULTS: HIV-1 nucleic acid was detected in urine samples from at least one time point in 8/20 (40%) treatment-naïve subjects compared to 1/13 (7.7%) individuals on antiretroviral treatment (ART) during periods of plasma viral suppression and 1/7 (14.3%) individuals with virological failure. HIV-1 RNA was undetectable in urine samples after ART initiation but HIV-1 DNA was detectable in one patient more than 6 months after treatment initiation. There was co-clustering of urine-derived pol sequences but some urine-derived sequences were interspersed among the plasma-derived sequences. CONCLUSIONS: Suppressive ART reduces HIV-1 replication in the urinary tract but HIV-1 DNA may persist in these cells despite treatment. A larger number of sequences would be required to confirm HIV compartmentalization in the urinary tract.


Assuntos
Genótipo , Infecções por HIV/virologia , HIV-1/classificação , HIV-1/isolamento & purificação , Sistema Urinário/virologia , Adulto , Antirretrovirais/uso terapêutico , DNA Viral/genética , DNA Viral/isolamento & purificação , Feminino , Infecções por HIV/tratamento farmacológico , HIV-1/genética , Humanos , Masculino , Projetos Piloto , Plasma/virologia , Estudos Prospectivos , RNA Viral/genética , RNA Viral/isolamento & purificação , Análise de Sequência de DNA , Carga Viral , Produtos do Gene pol do Vírus da Imunodeficiência Humana/genética
2.
Clin Infect Dis ; 54 Suppl 4: S334-8, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22544199

RESUMO

Surveillance of human immunodeficiency virus type 1 transmitted drug resistance (TDR) was conducted among pregnant women in South Africa over a 5-year period after the initiation of a large national antiretroviral treatment program. Analysis of TDR data from 9 surveys conducted between 2005 and 2009 in 2 provinces of South Africa suggests that while TDR remains low (<5%) in Gauteng Province, it may be increasing in KwaZulu-Natal, with the most recent survey showing moderate (5%-15%) levels of resistance to the nonnucleoside reverse transcriptase inhibitor drug class.


Assuntos
Antirretrovirais/farmacologia , Infecções por HIV/epidemiologia , Infecções por HIV/transmissão , HIV-1/classificação , Adolescente , Adulto , Farmacorresistência Viral , Feminino , Técnicas de Genotipagem , Infecções por HIV/virologia , HIV-1/efeitos dos fármacos , HIV-1/genética , Humanos , Vigilância da População , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Complicações Infecciosas na Gravidez/virologia , Estudos Retrospectivos , África do Sul/epidemiologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa